Não possui cadastro?

Cadastre-se

Já possui conta?

Faça login

Pagamento aprovado... Acessos liberados

Seu pedido foi aprovado com sucesso

Já liberamos o acesso ao espaço exclusivo para assinantes.

Acessar área exclusiva

Pedido não processado :(

Infelizmente o seu pedido não foi processado pela operadora de cartão de crédito

Tente novamente clicando no botão abaixo

Voltar para o checkout

Busca

Buscar

Fundo do Mockup Ícone do Mockup

ÖAG 2023 Congress

ÖAG 2023 Congress

19.10.2023
Fundo do Mockup Ícone do Mockup

A scoping review of obesity education interventions for current and prospec...

A scoping review of obesity education interventions for current and prospective medical professionals in Canada

28.11.2023
Fundo do Mockup Ícone do Mockup

Changes in the prevalence of U.S. adults using diet, exercise, pharmaceutic...

Changes in the prevalence of U.S. adults using diet, exercise, pharmaceuticals and diet products for weight loss over time: Analysis of NHANES 1999–2018

24.01.2024
Fundo do Mockup Ícone do Mockup

Use and continuity of weight‐modifying medications among adults with diab...

Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study

16.01.2024
Fundo do Mockup Ícone do Mockup

Early- and later-stage persistence with antiobesity medications: A retrospe...

Early- and later-stage persistence with antiobesity medications: A retrospective cohort study

16.01.2024
Fundo do Mockup Ícone do Mockup

Game changers: do new medications make lifestyle‐based treatment of obesi...

Game changers: do new medications make lifestyle‐based treatment of obesity obsolete?

16.01.2024
Fundo do Mockup Ícone do Mockup

At obesityweek, more data and questions about semaglutide, tirzepatide, and...

At obesityweek, more data and questions about semaglutide, tirzepatide, and retatrutide

18.12.2023
Fundo do Mockup Ícone do Mockup

The role of lifestyle modification with second-generation anti-obesity medi...

The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities

18.12.2023
Fundo do Mockup Ícone do Mockup

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with...

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity

18.12.2023
Fundo do Mockup Ícone do Mockup

Incomplete data and potential risks of drugs in people with obesity

Incomplete data and potential risks of drugs in people with obesity

18.12.2023